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 Antimicrobial resistance has been an exponentially growing problem since the 
discovery of antibiotics. Antibiotics have been misused for many years and this misuse 
has grown into a real problem for the medical community. While there are countless 
safeguards to prevent infection by a resistant strain of bacteria, there are still many 
plagued by it and must be treated with sometimes dangerous antibiotics. Melittin, along 
with many other peptides, contain potent antimicrobial properties, but are also toxic 
toward enthrocytes. The control of the secondary structure of peptides provides the key to 
adjusting their activity.    
 
1 
CHAPTER ONE ANTIMICROBIAL POLYPEPTIDES 
Introduction 
Antimicrobial resistance has been an exponentially growing problem since the 
discovery of antibiotics. The misuse of antibiotics is a major driving force for antibiotic 
resistance. The first source of misuse was during the golden age of antibiotics, when there 
was very little resistance. Antibiotics would be prescribed for the slightest symptoms, 
with this wide spread use bacteria found ways to adapt and resist the drugs.1 Another 
source of misuse is in medical patients, when a prescription is not taken as directed. 
Patients across the globe, especially in less developed countries, have said that they save 
or do not finish the prescription.2 Overuse in agriculture is another major source of 
resistance. In 2010 the FDA released a report estimating that the use of antibiotics in food 
animals was over 11 million kilograms were used in 2009, and 2011 the number has rose 
to 13.5 million kilograms.3 After bacteria encounter a class of antibiotics over several 
generations, the antibiotic becomes less effective and resistance is born. 
Resistance is formed by mutations in the bacterial DNA that evolve mechanisms 
to counter antibiotics. β-lactams are a class of antibiotics which block a pathway in the 
production of the cell wall, thereby killing the bacteria. β-lactams such as penicillin or 
amoxicillin are the workhorse of antibiotics and are the most prescribed antibiotics 
available. As such, the resistance to β-lactams has risen dramatically. The mechanism of 
2 
bacterial resistance has been pinpointed to β-lactamase enzymes. These enzymes cleave 
the lactam ring making the β-lactam compounds inert. There are several groups of β-
lactamase enzymes, each are capable of a range of mechanisms. For example, some β-
lactamase enzymes are capable of being inhibited by clavulanic acid, a β-lactam mimetic. 
However, there are also some that show resistance to clavulanic acid. These data point to 
the necessity for novel strategies to combat resistance. 
There is not only a biological cost to the increase in bacterial resistance but a 
societal cost as well. Increasing resistance brings with it increased mortality and health 
care expenses. For salmonella, a fairly common source for food poisoning, the mortality 
rate against resistant strains is 3.4%, while only 0.2% for non-resistant strains.4 The 
increased patient cost to treat resist strains of bacteria in the United States is greater than 
8 billion US dollars.5  
 
Antimicrobial Peptides 
Antimicrobial resistance from misuse of antibiotics has created a global health 
concern which draws the need for novel types of antimicrobial therapeutics. 
Antimicrobial peptides  are short, 15-40 amino acids, peptides that are a part if the innate 
immune response in organisms.6 Many isolated AMPs have been shown to have activity 
against a wide array of organisms including Gram-positive and Gram-negative bacteria, 
fungi, and viruses.7 The diverse mechanisms of activity or AMPs include formation of 
pores in the membrane, inhibiting proteins, and triggering autolysis.6 Antimicrobial 
3 
peptides are attractive as a new class of clinical antibiotics because of their broad 
spectrum of activity and diverse mechanisms in contrast to small molecule antibiotics.8 
Antimicrobial peptides (AMPs) first came into light in the 1980’s when Boman, 
Zasloff, and Lehrer concurrently isolated AMPs from separate animal kingdoms.9,10 
Notably, in Zasloff’s lab, it was noticed that infections rarely occurred after non-sterile 
surgical procedures with the African clawed frog Xenopus laevis.11 It was discovered that 
small peptides in the skin had broad spectrum antibacterial properties, and these peptides 
became known as magainins.11 Since the discovery of the first AMPs over 800, have been 
found throughout the animal and plant kingdom.12 
There are several inherent characteristics associated with AMPs. AMPs are 
usually short, less than 50 amino acids, and contain a cationic amphipathic structure.13 
AMPs are classified by their amino acids and secondary structure: α-helix, β-sheet, 
cysteine containing, containing many standard AA, and containing modified AAs.7 
Cecropins, one of the first classes identified, is a cationic amphipathic peptide isolated 
from Hyalophora cecropia.14 Through NMR studies it was determined that cecropins 
form an α-helix in 15% HFIP.15 Peptides which form α-helical secondary structures are 
most known for their pore forming mechanism. Some well studied peptides with this 







Table 1.1: Amino acid sequences of cecropin-A, magainins-II, protegrin-1, melittin and 













Sources of Antimicrobial Peptides 
 As stated earlier, the first AMPs isolated were from amphibians and many more 
AMPs have since been isolated from a plethora of species, including insects, plants, 
animals, and humans. Additionally, these peptides have a broad range of secondary 
structures and activity against different types of invasive organisms.20 This menagerie of 
structure, activity, and chemical properties is a hotspot for the development of novel 
therapeutics.       
AMPs in invertebrates were first isolated from Hyalophora cecropia, commonly 
known as the Cecropia moth, the largest moth in North America.21 These peptides 
became known as ceropins and have broad spectrum activity against protozoa, bacteria, 
and fungi.7 Since the initial discovery of AMPs of the Cecropia moth several unique 
AMPs have been identified in many other invertebrates ranging from honey bees to crabs. 
5 
A sample of some of those peptides can be seen in table 1.2 with their respective 
activities.  
 
Table 1.2: Examples of antimicrobial peptides isolated from invertebrates  
Source Peptide Activity 
Drospohila melanogaster Drosomycin F 
Diptericin G- 
Aedes Aegypti Defensin-α G-,G+ 
Defensin-β G-,G+ 
Apis mellifera Mellitin G-,G+, H 
Defensin G-,G+ 
Royalisin G-,G+ 
Lycosa carolinensis Lycotoxin G-,G+ 
Stomoxys calcitrans Smd1 G-,G+ 
Smd2 G-,G+ 
Tachypleus tridentatus Tachyplesin G-,G+ 
Limulus polyphemus Tachyplesin II G-,G+,F 
Polyphemnsin I G-,G+,F 
Polyphemnsin II G-,G+,F 
Androctonus australis Androctonin G-,G+,F 
Mytilus edulis Mytilin A G-,G+ 
Hyalophora cecropia Cecropin G- 
G-, Gram Negitive; G+, Gram Positive; F, antifungal; H, Hemolytic 
 
 
With the initial discovery of AMPs in amphibians and soon invertebrates, it 
wasn’t long until AMPs were being discovered in many other species including plants 
and other vertebrates. Defensins are a group of AMPs that are found in several different 
mammals including humans and rabbits, and they also have been isolated from plants and 
insects.22 Defensins are 41 amino acids in length and are characterized by their disulfide 
6 
bridges. Defensins are classified into sub-categories depending on the arrangement of the 
disulfide bridges.  
 
Antimicrobial Peptides with α-helix Secondary Structure 
 Particular classes of AMPs are highly predisposed to form pores in plasma 
membranes. α-helical AMPs are one such class that lyses pathogens and erythrocytes. An 
α-helical AMP's first interaction with a target is electrostatic due to the cationic amino 
acids (AAs) interacting with the negatively charged heads of the phospholipids in the 
plasma membrane or other negatively charged components on the cell wall. There is 
much speculation about the mechanism of pore forming peptides, but the consensus is 
that three types of mechanisms exist: toroidal pore, carpet model, and barrel stave.23 
 
Mechanism of Action 
The barrel stave model, figure 1.1, describes a mechanism where the peptides 
integrate into the plasma membrane and form a pore. The amphiphatic characteristics of 
the peptide make this possible in that the hydrophobic features of the peptide is faced 
outward toward the hydrophobic tails of the membrane and the hydrophilic face forms an 
aqueous pore.24 One peptide alone cannot form the aqueous pore, therefore, many 
peptides come together to form the pores. Some AMPs, such as melittin, utilize a 
structural feature known as the leucine zipper to hold the pore together.25 The stability of 
the hydrophobic interactions and the leucine zipper allow for the intercellular material to 
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the Shultz laboratory synthesized model peptides and incorporated a disulfide bridge at 
the i, i + 7 positions.32 Taylor incorporated amide bonds into model peptides utilizing the 
natural functional groups of lysine and aspartic acid or glutamic acid.33 The formation of 
the amides stabilized the helical structure when compared to the acyclic analogue. While 
these methods could provide triggers, as with the disulfide bonds, or permanent 
modifications with amide bonds, more reversible methods could provide great value.      
 Metal – ligand interactions allow a lot of variability and exploration with various 
metals. For example, Paul Hopkins’ laboratory used various divalent metal ions to 
stabilize the helicity of model peptides.34 The study found that Co(II), Ni(II), Cu(II), 
Zn(II), and Cd(II) all had a positive effect with most of the peptides. In another study by 
Futaki et al, the group was able to stabilize or destabilize model peptides using 
iminodiacetic acid.34 The group made another step to selectively destabilize the Jun-Fos 
herterodimer to form a Jun-Jun homodimer.31 The destabilizing of one peptide in the 
heterodimer changes the natural recognition of the dimer.    
 
Siderophores 
 Iron is a critical metal in many organisms as it is needed to do a range of activities 
in different enzymes. In mammals iron is needed to transport oxygen in the blood and is a 
cofactor of superoxide dismutase which neutralizes harmful radicals in the body. Iron is 
also required by bacteria. For example, in E. Coli it is a cofactor in 3-deoxy-D-
arabinoheptulosonate 7-phosphate (DAHP) synthase which is used to make aromatic 
compounds and is in the biosynthetic pathway to produce the aromatic amino acids.35 
12 
Bacteria obtain iron by releasing a class of compounds known as siderophores. These 
compounds have some of the highest known binding constants to iron(III). For example, 
enterobactin, is the siderophore released by E.Coli for iron scavenging. Enterobactin 
binds to iron with the catechol moieties and is brought into the cell by transport proteins 
which have receptors on the cell surface.36 Rhodotorulic acid is another siderophore 
isolated form  Rhodotorula pilimanae.37 Unlike enterobactin which is a catechol based 
siderophore, rhodotorulic acid is a hydroxymate. Additionally, rhodotorulic acid contains 
only four binding sites, a complex of Fe2(RA)3 must be formed.
 Pyochelin is another 
siderophore isolated from Pseudomonas aeruginosa.38 Pyochelin is unique in its structure 
compared with other siderophore which are usually rich in catechols or hydroxymates. 
 
 
Figure 1.5: Structures of enterobactin(top), pyochelin(bottom left), and rhodotorulic 
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CHAPTER TWO MELITTIN ANALOGUES 
 
Melittin 
Melittin is a hemolytic AMP isolated from the European honey bee Apis 
mellifera. Melittin is the primary toxic component in bee venom and accounts for 
approximately 50% of the dry mass. Melittin, figure 2.1, is a short linear peptide 
containing 26 amino acids (GIGAVLKVLTTGLPALISWIKRKRQQ-NH2). The residues 
at the N-terminus are mostly hydrophobic while the residues at the C-terminus are mainly 
hydrophilic due to the basic amino acids. The properties of melittin have promoted its use 
as a model peptide for hemolytic peptides.  
 
 
Figure 2.1: The structure of melittin. 
 
Melittin, as with other cytolytic peptides, is mainly hydrophobic, however the 
peptide has a net charge of +6 at physiological pH. Most of this charge, +4, is located on 
the highly basic C-terminus containing Lys-Arg-Lys-Arg. Figure 2.2 shows that most of 
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against E. Coli, 3.9 μM.7 The exploitation of this low MIC and the reduction of hemolytic 
activity has been the focus of much research.       
 
 
Structural Requirements for Activity 
 
 Several extensive studies of melittin have determined that the hemolytic and 
antibacterial activities are independent of one another. In the early structural activity 
relationship studies in to the requirements of melittin it was determined the N-terminal 1-
20 residues play mainly a structural role in melittin’s absolute activity.8 Additionally, it is 
determined that the C-terminal 21-26 residues are a necessary component for hemolytic 
activity.8 However, more recent studies have proven that this is not the case.  
 In a comprehensive study by Blondelle and Houghten, the necessary residues 
were discovered for melittin’s hemolytic and antibacterial properties. The individual 
omission of Leu-6, Leu-9, Leu-13, or Leu-16 give an over 100-fold decrease in hemolytic 
activity.9 This is also evidence to support the need for the leucine zipper design for 
aggregation in the plasma membrane. The omission of Ile-17 and Trp-19 also leads to 
considerable decrease in hemolytic activity. However, the omission of the previously 
described amino acids did not have the same drastic effects on the antibacterial activity. 
Only a 2-fold or 3-fold decrease in antibacterial activity was observed in contrast to the 
100-fold seen in the hemolytic studies.  
Blondelle and Houghten also explored an individual leucine substitution of each 
amino acid in the melittin peptide. It is interesting to note that at 19 amino acids that were 
substituted had considerably higher hemolysis percentage than the unadulterated 
20 
melittin.10 Two amino acids of note, Lys-7 and Trp-19 had detrimental effects on the 
hemolytic activity when substituted, even at the highest concentrations tested.10 
Unfortunately, the antibacterial activity was not probed with these analogues.     
A core requirement for hemolytic activity is the amphiphilic helical secondary 
structure, yet the helical structure is not a requirement for antibacterial activity. In a study 
by Oren and Shai, four amino acid residues, Val-5, Val-8, Iso-17 and Lys-21, were 
replaced with D-isomers of the respective amino acids. The melittin analogue showed a 
low propensity to form a helical secondary structure. Because the peptide had low 
propensity for helix formation, the hemolytic activity was also low, yet there was still a 
significant level of antibacterial activity.11 
 
Truncated Melittin 
 As described previously, it is documented that the N-terminus plays a minimal 
role with the mechanism for antibacterial activity. As such, researchers have explored 
using truncated melittin fragments to determine their viability as therapeutics. Extensive 
studies have focused on the fragment around residues 12-25, figure 2.4, containing the C-
terminal basic amino acids.12-14 The peptide has a lower propensity to form a helical 
secondary structure which makes it an ideal lead compound to study. As a result, the 




Figure 2.4: The structure of truncated melittin(12-25). 
 
1st Genertation Melittin Derivatives 
The current project explored the coupling of melittin, metal destabilization, and 
siderophores as targeted antimicrobial peptides..  Previous studies have shown that Thr-
10 and Lys-21 are not critical for antibacterial activity, so, in the present project, these 
sites were selected for incorporation of ligands for metal binding. Thr-10 was changed to 
Lys-10 to be able to couple the ligand to the peptide at residues 10 and 21. Two ligands 
were selected to determine the possible differences between bidentate ligand and 




Figure 2.5: Placement of metal binding moieties to melittin, where X represents 
bipyridine or terpyridine. 
 
 
The design of this work was to use metal chelation to deactivate the peptide’s 
hemolytic activity and retaining antibacterial activity with a metal-ligand switch. The 
targeted activity will activate once a siderophore from a bacteria will remove the metal 
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Synthesis of Metal Binding Moieties 
 
 
Scheme 2.1: Synthesis of metal binding ligands. 
 
To preserve the positive charge required for melittin activity, two neutral metal 
binding ligands were chosen as chelators, 4-methyl-2,2'-bipyridine-4'-carboxylic acid  
and 2,2’:6’, 2”-terpyridine-4’-carboxylic acid, scheme 2.1. The carboxylic acid moieties 
will be used to couple the ligand to a lysine residue with the modified melittin. The 
compounds were synthesized according to literature procedures. To synthesize the 
bipyridyl compound 3, commercially available compound 1 was selectively oxidized 
with selenium dioxide. Compound 2 was further oxidized with silver oxide to afford the 
carboxylic acid in compound 3.16 The terpyridyl compound 6 was synthesized by treating 
commercially available citrazinic acid (4) with phosphorous oxybromide to produce 
compound 5.17 The dibromide compound 5 was then used in a Stille coupling reaction 
using a palladium catalyst and 2-(tributylstannyl)pyridine to provide the desired final 
product, compound 6.18 The methyl ester is hydrolyzed during the work up procedure. 
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Synthesis of Melittin Derivatives 
 
 
Scheme 2.2: Synthesis of melittin derivatives, where X is terpyridine or bipyridine.   
 
 The melittin derivatives MLT-bpy and MLT-tpy, figure 2.5, were synthesized by 
solid phase peptide synthesis following the Fmoc based protocol. 4-methyltrityl (Mtt) 
protected lysine was used to selectively allow binding of the ligand to the desired lysine 
residue. Other lysine residues were protected with the allyloxycarbonyl (alloc) protecting 
group. The solid support for the synthesis was the ChemMatrix rink amide resin with a 
0.52 mmol/g loading. The coupling reactions were monitored using the ninhydrin test 
(Kaiser test) for primary amines and the chloranil test for secondary amines. Once the 
peptide was completed, the Mtt protecting groups were removed with 1.8% 
trifluoroacetic acid in methylene chloride. The reaction mixture was drained and a yellow 
solution indicated the removal of the protecting group. More deprotection cocktail was 
added and repeated until little to no color appeared in the reaction mixture. The ligand 
compounds were coupled to the free amine of the deprotected lysine using standard 
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HBTU coupling. The remaining Alloc protecting groups were deprotected using a 
palladium catalyzed decoupling procedure. The peptides were cleaved from the resin with 
non-acid liable protecting groups removed with a cleavage cocktail composed of 95% 
TFA, 2.5% TIPS, 2.5% water. The peptides were then purified by reverse phase HPLC 
and characterized Matrix-assisted laser desorption ionization (MALDI) mass 
spectroscopy, table 2.1.           
 
Table 2.1: Purification of melittin derivatives. 
Compound 








MLT-bpy 35-70 25 min 3308.04 3308.99 




 Circular dichroism experiments were conducted to determine helicity of the 
designed peptides, figure 2.7. In 100mM phospate buffer at pH 7.4 showed that the 
peptide was found to form an α-helix. Interestingly, when iron (II) as added to the 
peptides in solution, little change was observed in the helicity of MLT-bpy, but the 
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similar antibacterial activity. The metal ligands were also moved to the terminus of the 
peptide in an effort to have less effect on activity. Four truncated peptides, figure 2.10; 
containing melittin residues 12-25 with metal binding ligands were synthesized to 
determine their antibacterial activity with and without metal ions. Two of the peptides 
contained a single ligand on each of the C- and N- termini of the peptides as shown 
below. The third peptide contained ligands at both termini. We also prepared a truncated 
12-25 residue melittin fragment as a control peptide. The same synthetic strategy was 
used to attach the ligand to the lysine residues. A glycine spacer was between the 
truncated peptide and the ligand-modified lysine residues at the termini.       
 
 
Figure 2.10: Second generation melittin derivatives. From top to bottom: MLTx, MLTx1, 
MLTx2, MLTx3. Where X is terpyridine. 
 
 
Synthesis of 2nd Generation Melittin Derivatives 
 The new peptides were synthesized in the same manner as described previously. 
Terpyridine and bipyridine were used as ligands, however, the coupling of of the 
bipridine MLTx1 proved to be difficult and was abandoned, nevertheless, MLTx2-bpy 
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was completed. Given that bipyridine is a bidentate ligand and would most likely bridge 
multiple peptides leading to higher ordered structures, only terpyridine was used in the 
synthesis of MLTx3. The peptides were then purified by reverse phase HPLC and 
characterized Matrix-assisted laser desorption ionization (MALDI) mass spectroscopy, 
table 2.2.           
 
Table 2.2: Purification of truncated melittin derivatives. 
 
Compound 








MLTx 10-50 38 min 1887.28 1886.45 
MLTx1-tpy 10-40 48 min 2109.52 2110.01 
MLTx2-tpy 20-50 30 min 2110.98 2109.96 





 UV/Vis spectroscopy was used to monitor that the ligands within the peptide are 
chelating the metal. There is a distinctive charge transfer that occurs between terpyridine 
and iron(II),  with the λmax for the terpyridine-iron(II) complex occurring at around 
570nm. The spectra below show that the charge transfer is occurring, demonstrating that 
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it has a longer sequence. The truncated melittin fragments did not possess appreciable 
helicity in the 10 mM phosphate buffer, but, unexpectedly MLTx3-tpy did possess 
moderate helicity in 10 mM phosphate buffer. Furthermore, all peptides showed 
appreciable helicity in 10% HFIP, figure 2.14. Hexafluoroisopropanol is commonly used 
to induce helicity of peptides which form α- helical secondary structures.  
When metal ions were added to the peptides, figure 2.14, it was observed that the 
helix is destabilized in solution. Interestingly, the denatured peptide appears to retain 
more helical characteristics. The peptide was denatured in 10 mM urea solution, then iron 
(II) was added to solution. The urea was removed from solution by dialysis filtration. The 
denaturing of the peptide was necessary because of the possibility that the peptide may be 
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MLTx1 or MLTx2 containing the terpyridine ligand. However, some decrease in 
antibiotic activity did occur with MLTx3-tpy. A denatured peptide, MLTx3d-tpy, was 
also tested. The peptide was first denatured in 10mM urea, then the metal ion was added 
to solution. The solution was than dialyzed to remove the urea from the solution. By 
denaturing the peptide, the activity of the peptide-metal complex (MLTx3d: Fe(II)) was 
lowered 2-fold as compated to the non-denatured sample (MLTx3: Fe(II)).        
 
Table 2.3: MIC of melittin derivatives.  
Peptide E.Coli S. Aureus 
Melittin 4 μM ± 0.002 1 μM ± 0.006 
MLTx >64 μM ± 0.02 - 
MLTx1-tpy 16 μM ± 0.001 8 µM ± 0.019 
MLTx2-tpy 16 μM ± 0.02 8 µM ± 0.02 
MLTx3-tpy 8 μM ± 0.012 8 µM ± 0.009 
MLTx1-tpy: Fe(II) 16 μM ± 0.08 8 μM ± 0.02 
MLT2x-tpy: Fe(II) 16 μM ± 0.02 8 μM ± 0.02 
MLTx3-tpy: Fe(II) 16 μM ± 0.006 8 μM ± 0.01 
MLTx3d-tpy: Fe(II) 32 μM ±0.020 16 μM ± 0.02 
 
 
Reversibility of the Metal-Ligand Interaction 
 Terpyridine-Fe(II) interactions are known to be reversible in polymers and 
peptides.21,22 However, attempts to remove the metal ion from the melittin derivatives has 
proven to be very difficult. Several solvents and chelators were used to attempt the 
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 Melittin derivatives are susceptible to small changes which have major impact to 
their activity. The 1st-generation peptides ultimately failed to maintain any antibacterial 
activity. The addition of the aromatic ligands at residues 10 and 21 was enough to reduce 
the antibacterial activity 30-fold. However, the truncated peptides show promise as novel 
antibacterials as they have retained most of their activity. Unfortunately, the difficulty of 
reversing the metal-ligand interaction is a problem that needs to be solved to move the 
project further.  
 
Materials and Methods 
 All peptides were synthesized on Rink amide resin (200-400 mesh) purchased 
from novabiochem. Critizanic acid and  4,4'-dimethyl-2,2' bipyridine were both 
purchased from VWR International. Other reagents used were purchased from Sigma-
Aldrich or VWR International. The peptides were purified and analyzed with Waters 
Delta Prep 4000 HPLC. The ligand intermediates and final compounds were 
characterized by NMR spectroscopy with the Varian Inova-300 Mhz nuclear magnetic 
resonance (NMR) spectrometer. All peptides were characterized by mass spectrocopy 
using an Applied Biosystems Voyager-DE Matrix-assisted laser desorption ionization – 
time of flight mass spectromerter. Circular dichroism experiments were performed on a 
Jasco J-810 circular dichroism spectrophotometer. UV/Vis spectra were obtained on a 





4-methyl-2,2'-bipyridine-4'-carboxaldehyde(2) To a dry 500 ml round bottom flask 
was added  4,4'-dimethyl-2,2' bipyridine (1) (5.00 g, 27 mmol) followed by 200 ml 
dioxane. The solution was sparged with nitrogen for 15 minutes with stirring. Selenium 
dioxide (3.31 g, 30 mmol) was then added and the solution was sparged while stirring for 
15 minutes. The solution was heated to a gentle reflux for 24 hours. After cooling the 
reaction mixture was vacuum filtered and the solvent removed. The remaining solid was 
dissolved in 100 ml ethyl acetate and refluxed for an additional 1 hour and vacuum 
filtered while hot. The filtrate was washed with 0.1 M sodium carbonate followed by 0.3 
M sodium metabisulfate. The pH was then adjusted to 10 with solid sodium carbonate 
and then extracted with methylene chloride. (yield: 1.67 g, 31%) 1H-NMR (300 MHz, 
CD2Cl2) δ 10.19 (s, 1H), 8.84(d, 1H), 8.80(s, 1H), 8.52(d, 1H), 8.29(s, 1H), 7.71(d, 1H), 
7.22(d, 1H), 2.47(s, 3H) 
 4-methyl-2,2'-bipyridine-4'-carboxylic acid(3) To a dry 250 ml round bottom flask 
was added 95% ethanol/water solution followed by 4-methyl-2,2'-bipyridine-4'-
carboxaldehyde (2) (1.67 g, 8.40 mmol). An aqueous 20 ml solution of silver nitrate ( 
1.56 g, 9.20 mmol) was then added. A 1 M solution of sodium hydroxide (1.67 g, 42 
mmol) was added via an addition funnel for 20 minutes and the reaction mixture was 
stirred for 24 hours. The ethanol was removed by reduced pressure. The reaction mixture 
was then vacuum filtered and the solids washed with 2 M sodium hydroxide followed by 
water. The filtrate was extracted with methylene chloride. The pH of the aqueous solution 
was adjusted to 3. The lower pH allowed a white precipitate to form and was collected. 
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(yield: 0.746g, 41%) 1H -NMR (300 MHz, (CD3)2SO) δ 8.86(d, 1H), 8.81(s, 1H), 8.57(d, 
1H), 8.26(s, 1H), 7.86(d, 1H), 7.33(d, 1H), 2.48(s, 3H) 
2,6-Dibromoisonicotonic acid methyl ester (5) Phosphorous oxybromide (10 g, 35 
mmol) and citrazinic acid (4) (1.7 g, 11 mmol) were ground together, put in a dry 100 ml 
round bottom flask and purged with nitrogen. The reaction mixture was heated to    180 
ºC under an nitrogen atmosphere for 90 min. The mixture was then cooled to room 
temperature and quenched with anhydrous MeOH (10 mL). After dilution with saturated 
aqueous K2CO3 (20 ml), the solution was extracted with dichloromethane (3x20 ml). The 
organic layer was washed with brine and dried over sodium sulfate. The solution was 
decanted into a 1 inch silica plug and washed with DCM (3x15 ml). The filtrate solution 
was evaporated under lower pressure. No further purification was necessary. (yield: 2.22 
g, 68.5%) 1H -NMR (300 MHz, CD2Cl) δ 8.00(s, 2H), 3.97(s, 3H) 
2,2':6', 2"-terpyridine-4'-carboxylic acid (6) 2,6-Dibromoisonicotonic acid methyl 
ester (1.6 g, 5.4 mmol), tributylstannyl pyridine (3.51 ml, 10.8 mmol), and 
tetrakis(triphenylphosphine)palladium (0.63 g, 0.54 mmol) were dissolved in 50 ml dry 
toluene in a dry 150 ml round bottom flask. The reaction mixture was heated to 110° C 
under nitrogen for 16 hours. The reaction was monitored by TLC. Once the reaction was 
complete, the mixture was cooled to room temperature and quenched with saturated 
ammonium chloride (30 ml) and stirred for additional 30 minutes. The reaction mixture 
was filtered over celite and the filtered solids washed with DCM. The aqueous phase was 
extracted with DCM (3x15 ml). The organic phases were dried with sodium sulfate and 
the solvent removed. Concentrated hydrochloric acid (15 ml) was added to the residue to 
hydrolyze the methyl ester. The mixture was neutralized with 2 M sodium hydroxide and 
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extracted with DCM (3x10 ml). The organic layer was separated and the solvent 
evaporated. A 2/1 water/methanol mixture (25 ml) was added to the residue. 2 M sodium 
hydroxide solution (15 ml) was added and the mixture was stirred for 1 hour, this was to 
complete the hydrolysis of the methyl ester. The solution was extracted with DCM. The 
aqueous layer was then acidified to pH 3 and then the methanol removed under reduced 
pressure. The pH was adjusted to 6 which allowed a white precipitate to form. (yield: 
0.983 g, 65.6%) 1H -NMR (300 MHz, CD3OD) δ 8.86(s, 2H), 8.71(m, 4H), 8.02(td, 2H), 
7.49(qd, 2H) 
General Synthesis of Peptides. In a 20 ml peptide synthesis flask was added 200 mg 
Rink-Amide resin (0.052 mmol/g). The peptide was shaken with 10ml DCM to swell the 
resin. Fmoc-protected amino acids (6 equiv), HBTU (6 equiv), DIEA (12 equiv) were 
dissolved in 10 ml DMF and added to the resin. The synthesis flask was spun for 4 hours. 
The resin was washed with DMF, methanol, and DCM (3x10 ml). Piperidine (25% in 
DMF, 10 ml) was added to the resin and spun for 20 minutes and then drained. The 
peptide was washed with DMF, methanol, and DCM (3x10 ml). The procedure was 
continued until the peptide was complete.  
Kaiser Protocol Approximately 20 resin beads were removed from the synthesis flask 
and placed in a small culture tube. Three drops of ninhydrin solution (1.0 g of ninhydrin 
in 20 mL of n-butanol), three drops of phenol solution (40 g of phenol in 20 mL of n-
butanol), and three drops of KCN solution (dissolve 16.5 mg of KCN in 25 mL of 
distilled water. Dilute 1.0 mL of KCNaq solution with 49 mL of pyridine) were added to 
the culture tube. The mixture was added to a beaker of boiling water. If the beads turned 
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blue there is a free primary amine. If there is no color change or if the beads turn slightly 
brown there are not any free primary amines present.  
Chloranil Protocol Approximately 20 resin beads were removed from the synthesis flask 
and placed in a small culture tube. Three drops of chloranil solution (2% chloranil in 
DMF) and three drops of acetylaldehyde solution (2% acetylaldehyde in DMF) were 
added to the culture tube. The mixture was allowed to sit at room temperature. A blue-
green beads indicates a free secondary amine. A clear resin indicated were not any free 
secondary amines present. 
4-Methyltrityl (Mtt) deprotection The resin was washed with DCM then 15 ml of 1.8% 
TFA in chloroform and then added to the resin. The resin was allowed to stir for 4 
minutes. The yellow solution was drained and the resin washed with DCM. The 
procedure was continued until little yellow color evolved from the solution. 
Coupling of metal-chelating ligand The resin was washed with DMF. The ligand (6 
equiv), HBTU (6 equiv), DIEA (12 equiv) were dissolved in 10 ml DMF and added to the 
resin. The resin was spun for 4 hours then washed with DMF, methanol, and DCM (3x10 
ml). The resin was tested to ensure complete coupling. If a positive Kaiser test occurred, 
a second coupling procedure was performed.    
Aloc deprotection The resin was washed with chloroform and an aloc cleavage cocktail 
was added to the resin in 15 ml chloroform/acetic acid (0.5 mL per gram of resin), N-
methylmorpholine (2 mL per gram of resin), and Pd(PPh3)4 (0.3 equivalents based on 
resin substitution). The resin was spun for 45 minutes and analyzed by MALDI. If the 
reaction was not complete, the procedure was repeated if necessary.  
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CD Protocol A peptide sample was taken from the stock solution and diluted in 10 mM 
phosphate buffer solution pH 7.4 or 10% HFIP in water to make a 200 µL solution. The 
sample solution was scanned from 260 nm to 190 nm using a 1 nm bandwidth.  
UV/Vis Protocol A peptide sample was taken from the stock solution and diluted with DI 
water to a volume of 500 µL. 1 µL of a stock FeCl2 solution was added to the peptide 
solution and a color change was observed. The solution was then scanned.  
Denaturation Protocol A sample of stock peptide solution was diluted in a 10 mM urea 
solution. After 15 min 1 equivalent of a stock FeCl2 solution was added to the solution 
and a color change observed. The solution was then added to a dialysis tubing. The 
tubing was placed in a 1 L beaker containing DI water. The solvent was changed over 30 
minute intervals twice. The solvent was changed again and left overnight.  
Antibacterial Assay Procedure Bacteria were grown on a TSB agar culture plate 
overnight at 40° C. The bacteria were inoculated in 50 ml TSB media until the OD600 was 
between 0.4 and 0.6. 5 ml of the culture media was centrifuged and washed with MHB 
media (3x 5 ml). The culture media was diluted to an OD600 of 0.001. 90 µl of the 
bacterial solution was pipetted on a 96 well plate along with 10 µl peptide solution. The 
96 well plate was incubated at 40° C with shaking for 6 hours. The OD600 was taken and 
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